Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil as adjunctive treatment for focal-onset seizures in adults with drug-resistant epilepsy
jRCT2080224509Phase 2Completed
- Sponsor
- UCB
- Start
- Jan 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in refractory focal epilepsy comparing Padsevonil arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jan 2019; status: completed.
02
Drugs
padsevonil
03
Conditions
refractory focal epilepsy
Beyond the preview
Go deeper on jRCT2080224509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224509.